2024/09/27 20:22:43 | |
---|---|
Price | |
26.13 EUR | |
Difference | 0.83% (0.22) |
ISIN | US7170811035 |
Symbol | PFE |
Exchange | Tradegate |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 146,890 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 26.09 EUR (4,600) |
Ask (Ask size) | 26.11 EUR (4,600) |
Open | 25.865 EUR |
High | 26.20 EUR |
Low | 25.845 EUR |
Close (prev. day) | 25.915 EUR |
VWAP | 26.00922 EUR |
Volume (pcs) | 74,602 |
Trading volume | 1,940,362.51 |
Number of trades | 343 |
Last size | 250 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/09/27 20:22:43 | |
---|---|
Price | |
26.13 EUR | |
Difference | 0.83% (0.22) |
ISIN | US7170811035 |
Symbol | PFE |
Exchange | Tradegate |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 146,890 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 26.09 EUR (4,600) |
Ask (Ask size) | 26.11 EUR (4,600) |
Open | 25.865 EUR |
High | 26.20 EUR |
Low | 25.845 EUR |
Close (prev. day) | 25.915 EUR |
VWAP | 26.00922 EUR |
Volume (pcs) | 74,602 |
Trading volume | 1,940,362.51 |
Number of trades | 343 |
Last size | 250 |
6m | 1Y | 3Y | |
Perf (%) | +1.63% | -15.45% | -30.94% |
Perf (abs.) | +0.42 | -4.74 | -11.61 |
Beta | 0.26 | 0.20 | 0.39 |
Volatility | 23.29 | 25.65 | 26.36 |
Ø price 5 days | Ø volume 5 days (pcs.) | 26.21 EUR (68,831) |
Ø price 30 days | Ø volume 30 days (pcs.) | 26.19 EUR (55,968) |
Ø price 100 days | Ø volume 100 days (pcs.) | 26.44 EUR (64,800) |
Ø price 250 days | Ø volume 250 days (pcs.) | 26.41 EUR (89,617) |
YTD High | date | 29.53 EUR (2024/07/30) |
YTD Low | date | 23.56 EUR (2024/04/25) |
52 Weeks High | date | 32.55 EUR (2023/10/03) |
52 Weeks Low | date | 23.56 EUR (2024/04/25) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/09/27 | 17:35 | 26.125 EUR | 1.24 | 259 |
Vienna Stock Exchange | 2024/09/27 | 17:32 | 26.125 EUR | 0.00 | 5 |
Tradegate | 2024/09/27 | 20:22 | 26.13 EUR | 1.93 | 342 |
Stuttgart | 2024/09/27 | 19:02 | 26.125 EUR | 0.08 | 19 |
NYSE | 2024/09/27 | 20:23 | 29.1564 USD | 454.05 | 93,586 |
Munich | 2024/09/27 | 17:25 | 26.115 EUR | 0.00 | 2 |
London Stock Exchange | 2024/09/27 | 17:35 | 29.15 USD | 0.02 | 20 |
Hanover | 2024/09/27 | 17:25 | 26.115 EUR | 0.00 | 2 |
Hamburg | 2024/09/27 | 17:25 | 26.115 EUR | 0.00 | 3 |
Frankfurt | 2024/09/27 | 19:02 | 26.14 EUR | 0.42 | 27 |
Euronext Milan MTF Trading After Hours | 2024/09/23 | 18:24 | 26.365 EUR | 0.01 | 1 |
Euronext Milan MTF Global Equity Market | 2024/09/27 | 17:44 | 26.11 EUR | 0.04 | 7 |
Duesseldorf | 2024/09/27 | 19:31 | 26.16 EUR | 0.00 | 5 |
Berlin | 2024/09/27 | 08:08 | 25.865 EUR | 0.00 | 1 |
PFIZER INC. |
- - |
66 Hudson Boulevard East - 10001-2192 New York |
Telefon: +1-212-733-2323 |
Fax: + |
E-mail: - |
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY. |
Dan Littman | Member of Board of Directors |
Helen Hobbs | Member of Board of Directors |
Scott Gottlieb | Member of Board of Directors |
Susan Desmond-Hellmann | Member of Board of Directors |
Susan Hockfield | Member of Board of Directors |
Cyrus Taraporevala | Member of Board of Directors |
James Quincey | Member of Board of Directors |
James Smith | Member of Board of Directors |
Joseph Echevarria | Member of Board of Directors |
Ronald Blaylock | Member of Board of Directors |
Shantanu Narayen | Member of Board of Directors |
Suzanne Johnson | Member of Board of Directors |
Albert Bourla | Chairman of Managing Board |
Aamir Malik | Member of Executive Committee |
Alexandre de Germay | Member of Executive Committee |
Chris Boshoff | Member of Executive Committee |
Dave Denton | Member of Executive Committee |
Douglas M. Lankler | Member of Executive Committee |
Lidia Fonseca | Member of Executive Committee |
Mikael Dolsten | Member of Executive Committee |
Mike McDermott | Member of Executive Committee |
Payal Sahni Becher | Member of Executive Committee |
Rady A. Johnson | Member of Executive Committee |
Sally Susman | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer